Stay updated on ALT-801 in Overweight and Obese T2DM: Clinical Trial
Sign up to get notified when there's something new on the ALT-801 in Overweight and Obese T2DM: Clinical Trial page.

Latest updates to the ALT-801 in Overweight and Obese T2DM: Clinical Trial page
- ChecktodayChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference2%
- Check8 days agoChange DetectedThe page has updated the dosing information for ALT-801, including new dosage levels and a change in the BMI classification for obesity. Additionally, the study director's name has been added.SummaryDifference7%
- Check15 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference2%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
Stay in the know with updates to ALT-801 in Overweight and Obese T2DM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALT-801 in Overweight and Obese T2DM: Clinical Trial page.